close

SEARCH PROGRAMS

Pancreatic cancer and renal cancer are difficult to be treated by chemical drugs. Butyrolactams and their derivatives are reported to have anti-cancer and anti-angiogenesis activities. We intend to develop novel butyrolactams drug for pancreatic cancer and renal cancer treatment by using chemical synthesis, cell culture, and zebrafish embryos.
  • Field: Medicine & Public Health
  • School: Tamkang University
  • Organizer: Department of Chemistry
  • Period of Apply: Please contact us to confirm the period of application!
  • Term: Please contact us!
  • Tuition Fee: Please contact us!
  • Contact Person:Prof. Yau-Hung Chen
  • Email:yauhung@mail.tku.edu.tw

CONTACT US